Molecular aspects of soluble guanylyl cyclase regulation

Stavroula Andreopoulos, Andreas Papapetropoulos

Research output: Contribution to journalReview article

63 Citations (Scopus)

Abstract

Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme (comprised of α and β subunits) that generates the intracellular second messenger cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP is subsequently important for the regulation of protein kinases, ion channels, and phosphodiesterases. Since recent evidence has demonstrated that heterodimerization of the α/β subunits is essential for basal and stimulated enzymatic activity, the existence of several types of isoforms for each of the two subunits, along with their varying degrees of expression in different tissues, implies that multiple regulatory mechanisms exist for sGC. Yet, progress in studying and clarifying the regulatory processes that can alter sGC expression and activity has only slowly started being elucidated. In the following paper, we elaborate on sGC structure, function, and distribution along with recently described signaling pathways that modulate sGC gene expression. Copyright (C) 2000 Elsevier Science Inc.

Original languageEnglish (US)
Pages (from-to)147-157
Number of pages11
JournalGeneral Pharmacology: The Vascular System
Volume34
Issue number3
DOIs
StatePublished - Dec 18 2000
Externally publishedYes

Fingerprint

Cyclic GMP
Phosphoric Diester Hydrolases
Second Messenger Systems
Guanosine Triphosphate
Ion Channels
Protein Kinases
Protein Isoforms
Soluble Guanylyl Cyclase
Gene Expression
Enzymes

Keywords

  • Cyclic guanosine monophosphate (cGMP)
  • Nitric oxide (NO)
  • Soluble guanylyl cyclase (sGC)

ASJC Scopus subject areas

  • Pharmacology

Cite this

Molecular aspects of soluble guanylyl cyclase regulation. / Andreopoulos, Stavroula; Papapetropoulos, Andreas.

In: General Pharmacology: The Vascular System, Vol. 34, No. 3, 18.12.2000, p. 147-157.

Research output: Contribution to journalReview article

@article{e2cfe9e5f5e649be99696a93d1b5b370,
title = "Molecular aspects of soluble guanylyl cyclase regulation",
abstract = "Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme (comprised of α and β subunits) that generates the intracellular second messenger cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP is subsequently important for the regulation of protein kinases, ion channels, and phosphodiesterases. Since recent evidence has demonstrated that heterodimerization of the α/β subunits is essential for basal and stimulated enzymatic activity, the existence of several types of isoforms for each of the two subunits, along with their varying degrees of expression in different tissues, implies that multiple regulatory mechanisms exist for sGC. Yet, progress in studying and clarifying the regulatory processes that can alter sGC expression and activity has only slowly started being elucidated. In the following paper, we elaborate on sGC structure, function, and distribution along with recently described signaling pathways that modulate sGC gene expression. Copyright (C) 2000 Elsevier Science Inc.",
keywords = "Cyclic guanosine monophosphate (cGMP), Nitric oxide (NO), Soluble guanylyl cyclase (sGC)",
author = "Stavroula Andreopoulos and Andreas Papapetropoulos",
year = "2000",
month = "12",
day = "18",
doi = "10.1016/S0306-3623(00)00062-8",
language = "English (US)",
volume = "34",
pages = "147--157",
journal = "Vascular Pharmacology",
issn = "1537-1891",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Molecular aspects of soluble guanylyl cyclase regulation

AU - Andreopoulos, Stavroula

AU - Papapetropoulos, Andreas

PY - 2000/12/18

Y1 - 2000/12/18

N2 - Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme (comprised of α and β subunits) that generates the intracellular second messenger cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP is subsequently important for the regulation of protein kinases, ion channels, and phosphodiesterases. Since recent evidence has demonstrated that heterodimerization of the α/β subunits is essential for basal and stimulated enzymatic activity, the existence of several types of isoforms for each of the two subunits, along with their varying degrees of expression in different tissues, implies that multiple regulatory mechanisms exist for sGC. Yet, progress in studying and clarifying the regulatory processes that can alter sGC expression and activity has only slowly started being elucidated. In the following paper, we elaborate on sGC structure, function, and distribution along with recently described signaling pathways that modulate sGC gene expression. Copyright (C) 2000 Elsevier Science Inc.

AB - Soluble guanylyl cyclase (sGC) is a heterodimeric enzyme (comprised of α and β subunits) that generates the intracellular second messenger cyclic guanosine monophosphate (cGMP) from guanosine triphosphate (GTP). cGMP is subsequently important for the regulation of protein kinases, ion channels, and phosphodiesterases. Since recent evidence has demonstrated that heterodimerization of the α/β subunits is essential for basal and stimulated enzymatic activity, the existence of several types of isoforms for each of the two subunits, along with their varying degrees of expression in different tissues, implies that multiple regulatory mechanisms exist for sGC. Yet, progress in studying and clarifying the regulatory processes that can alter sGC expression and activity has only slowly started being elucidated. In the following paper, we elaborate on sGC structure, function, and distribution along with recently described signaling pathways that modulate sGC gene expression. Copyright (C) 2000 Elsevier Science Inc.

KW - Cyclic guanosine monophosphate (cGMP)

KW - Nitric oxide (NO)

KW - Soluble guanylyl cyclase (sGC)

UR - http://www.scopus.com/inward/record.url?scp=0033646732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033646732&partnerID=8YFLogxK

U2 - 10.1016/S0306-3623(00)00062-8

DO - 10.1016/S0306-3623(00)00062-8

M3 - Review article

VL - 34

SP - 147

EP - 157

JO - Vascular Pharmacology

JF - Vascular Pharmacology

SN - 1537-1891

IS - 3

ER -